Literature DB >> 2763857

Cortisol secretion in adolescents with major depressive disorder.

R Dahl1, J Puig-Antich, N Ryan, B Nelson, H Novacenko, J Twomey, D Williamson, R Goetz, P J Ambrosini.   

Abstract

Plasma cortisol concentrations were determined every 20 min for 24 h, in a nonstressful environment, among 48 rigorously assessed, mostly outpatient, drug-free adolescent subjects during an episode of major depression (MDD) and among 40 normal adolescent subjects. There were no significant differences in the 24-h mean, peak, or nadir, or the time of the nocturnal rise, in plasma cortisol in the 2 groups. Analyses of different subgroups of MDD adolescents according to suicidality, severity of depression, separation anxiety, psychotic subtype, endogenicity, duration of episode, and sex also revealed no significant group differences. Only one adolescent (with MDD) was identified clearly as a hypersecretor of cortisol. These results indicate that abnormalities of spontaneous cortisol secretion are an unusual finding among adolescents with major depression when studied in a nonstressful environment.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2763857     DOI: 10.1111/j.1600-0447.1989.tb01295.x

Source DB:  PubMed          Journal:  Acta Psychiatr Scand        ISSN: 0001-690X            Impact factor:   6.392


  12 in total

1.  Peri-sleep-onset cortisol levels in children and adolescents with affective disorders.

Authors:  Erika E Forbes; Douglas E Williamson; Neal D Ryan; Boris Birmaher; David A Axelson; Ronald E Dahl
Journal:  Biol Psychiatry       Date:  2005-08-22       Impact factor: 13.382

Review 2.  Recent undesirable life events: their influence on subsequent psychopathology.

Authors:  I M Goodyer
Journal:  Eur Child Adolesc Psychiatry       Date:  1996       Impact factor: 4.785

Review 3.  Disruption of fetal hormonal programming (prenatal stress) implicates shared risk for sex differences in depression and cardiovascular disease.

Authors:  J M Goldstein; R J Handa; S A Tobet
Journal:  Front Neuroendocrinol       Date:  2013-12-16       Impact factor: 8.606

4.  Behavioral adjustment in a community sample of boys: links with basal and stress-induced salivary cortisol concentrations.

Authors:  Audrey R Tyrka; Megan M Kelly; Julia A Graber; Laura DeRose; Janet K Lee; Michelle P Warren; Jeanne Brooks-Gunn
Journal:  Psychoneuroendocrinology       Date:  2010-03-11       Impact factor: 4.905

5.  Links between early baseline cortisol, attachment classification, and problem behaviors: A test of differential susceptibility versus diathesis-stress.

Authors:  Michelle C Fong; Jeffrey Measelle; Elisabeth Conradt; Jennifer C Ablow
Journal:  Infant Behav Dev       Date:  2017-02-05

6.  A dual-axis approach to understanding neuroendocrine development.

Authors:  Elizabeth A Shirtcliff; Andrew R Dismukes; Kristine Marceau; Paula L Ruttle; Julian G Simmons; Georges Han
Journal:  Dev Psychobiol       Date:  2015-07-29       Impact factor: 3.038

Review 7.  Hypothalamic-pituitary-adrenal axis dysregulation in depressed children and adolescents: a meta-analysis.

Authors:  Nestor L Lopez-Duran; Maria Kovacs; Charles J George
Journal:  Psychoneuroendocrinology       Date:  2009-05-05       Impact factor: 4.905

8.  Altered amygdala and hippocampus function in adolescents with hypercortisolemia: a functional magnetic resonance imaging study of Cushing syndrome.

Authors:  Françoise S Maheu; Luigi Mazzone; Deborah P Merke; Margaret F Keil; Constantine A Stratakis; Daniel S Pine; Monique Ernst
Journal:  Dev Psychopathol       Date:  2008

9.  Concurrent and longitudinal associations of basal and diurnal cortisol with mental health symptoms in early adolescence.

Authors:  Elizabeth A Shirtcliff; Marilyn J Essex
Journal:  Dev Psychobiol       Date:  2008-11       Impact factor: 3.038

10.  Associations between DSM-IV diagnosis, psychiatric symptoms and morning cortisol levels in a community sample of adolescents.

Authors:  Robert Young; Helen Sweeting; Patrick West
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2011-04-08       Impact factor: 4.328

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.